Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA ESTABLISHES AT-THE-MARKET FACILITY
* AURINIA PHARMACEUTICALS INC - MAY SELL THROUGH AT-THE-MARKET OFFERINGS COMMON SHARES HAVING AN AGGREGATE OFFER PRICE OF UP TO US$40 MILLION
* AURINIA PHARMACEUTICALS INC - INTENDS TO USE SALES PROCEEDS TO FUND ITS DRY EYE SYNDROME PROGRAM AND COSTS RELATED TO VOCLOSPORIN